
SAVANNAH RESOURCES PLC
SAV | IL
Overview
Corporate Details
- ISIN(s):
- GB00B647W791
- LEI:
- 213800UCK16HW5KKGP60
- Country:
- United Kingdom
- Address:
- SALISBURY HOUSE, EC2M 5PS LONDON
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Scancell Holdings PLC, founded in 1997, develops innovative immunotherapies for cancer and infectious diseases.Ê Its mission is to create therapeutic cancer vaccines using vaccine platforms (Moditope, ImmunoBody) and monoclonal antibody platforms (GlyMab, AvidiMab) to stimulate the patient's immune system.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-07-10 08:00 |
Investor Presentation
New Corporate Presentation
|
English | 15.0 KB | |
2025-07-02 08:00 |
Capital/Financing Update
Retail Offer increases Fundraise to £4.8 million
|
English | 28.3 KB | |
2025-06-27 08:20 |
Share Issue/Capital Change
Result of Accelerated Bookbuild and Subscription
|
English | 54.0 KB | |
2025-06-26 18:00 |
Share Issue/Capital Change
RetailBook Offer
|
English | 38.1 KB | |
2025-06-26 17:51 |
Share Issue/Capital Change
Proposed Fundraise
|
English | 147.2 KB | |
2025-06-18 14:27 |
Transaction in Own Shares
PDMR Notification
|
English | 27.8 KB | |
2025-06-10 13:04 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 24.3 KB | |
2025-05-29 08:02 |
Regulatory News Service
More encouraging results in third batch of assays
|
English | 270.6 KB | |
2025-05-14 08:00 |
Regulatory News Service
Research Initiation by Canaccord Genuity
|
English | 15.3 KB | |
2025-04-22 09:47 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 39.3 KB | |
2025-03-27 08:00 |
Regulatory News Service
Encouraging first assays from Phase 2 drilling
|
English | 185.0 KB | |
2025-03-25 16:58 |
Regulatory News Service
BLP designated as Strategic Project under EU CRMA
|
English | 22.0 KB | |
2025-02-21 08:00 |
Regulatory News Service
Restart of fieldwork at Project
|
English | 17.4 KB | |
2025-02-20 13:09 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 38.9 KB | |
2025-02-07 09:01 |
Regulatory News Service
Claim filed in relation to temporary land access
|
English | 17.6 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |